Source:http://linkedlifedata.com/resource/pubmed/id/12375269
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-10-10
|
pubmed:abstractText |
Tenascin-C (TN-C) is an extracellular matrix glycoprotein expressed along epithelial/stromal boundaries during tissue remodelling events, such as those that occur during morphogenesis, wound healing, and tumour invasion. Using clinical specimens and a range of in vitro models that simulate homeostasis, wound healing, and malignant progression, this study sought to establish the patterns of TN-C expression in normal and neoplastic bladder and to determine the role of exogenous transforming growth factor beta-1 (TGFbeta-1), interleukin-4 (IL-4), basic fibroblast growth factor (bFGF), tumour necrosis factor alpha (TNFalpha), and interferon gamma (IFNgamma) in the induction of TN-C expression by bladder uro-epithelial cells. The findings indicate that normal urothelial cells may express TN-C, with both TGFbeta-1 and IL-4 able to induce expression. TN-C was not expressed in neoplastic urothelium, although both TN-C and TGFbeta-1 may be involved in tissue remodelling during papillary tumour formation and invasion. Furthermore, the urothelium of high-grade papillary tumours and carcinoma in situ specimens exhibited little TGFbeta-1 immunoreactivity, compared with the urothelium of low-grade tumours and normal specimens, suggesting an association between TGFbeta-1 expression and urothelial differentiation. A tumour invasion model, in which established bladder cancer cell lines were seeded onto a normal bladder stroma, corroborated the evidence from the clinical specimens and demonstrated that TN-C was strongly expressed around foci of stromal invasion. Thus, TN-C immunoreactivity may provide an additional tool in the assessment of early stromal invasion in bladder cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/TGFB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tenascin,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-3417
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2002 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
198
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
359-68
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12375269-Carcinoma, Papillary,
pubmed-meshheading:12375269-Carcinoma in Situ,
pubmed-meshheading:12375269-Cytokines,
pubmed-meshheading:12375269-Humans,
pubmed-meshheading:12375269-Immunoenzyme Techniques,
pubmed-meshheading:12375269-Mucous Membrane,
pubmed-meshheading:12375269-Neoplasm Proteins,
pubmed-meshheading:12375269-Neoplasm Seeding,
pubmed-meshheading:12375269-Organ Culture Techniques,
pubmed-meshheading:12375269-Organoids,
pubmed-meshheading:12375269-Tenascin,
pubmed-meshheading:12375269-Transforming Growth Factor beta,
pubmed-meshheading:12375269-Transforming Growth Factor beta1,
pubmed-meshheading:12375269-Tumor Markers, Biological,
pubmed-meshheading:12375269-Urinary Bladder,
pubmed-meshheading:12375269-Urinary Bladder Neoplasms
|
pubmed:year |
2002
|
pubmed:articleTitle |
Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.
|
pubmed:affiliation |
Jack Birch Unit of Molecular Carcinogenesis, Department of Biology, University of York YO10 5YW, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|